Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel … Continue reading →

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) is a clinical-stage drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic inflammatory disease and neurologic disorders. The company’s lead compound, anatabine … Continue reading →

Rexahn Pharmaceuticals, Inc. (NYSE: RNN) is a clinical-stage biopharmaceutical company dedicated to the development of novel, best-in-class therapeutics for the treatment of cancer. The company’s product candidates work by targeting and neutralizing specific proteins believed to be involved in the … Continue reading →

RestorGenex Corporation (OTCQB: RESX) is a specialty biopharmaceutical company focused on the development of a portfolio of first-in-class therapeutic products to treat diseases across the oncologic, ophthalmologic and dermatologic space. The company’s lead product is a novel PI3K/Akt/mTOR pathway inhibitor … Continue reading →

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. The company currently has three drug candidates in clinical development for … Continue reading →

Reed’s, Inc. (NYSE: REED) produces the top-selling natural sodas in the natural foods industry and is sold in more than 15,000 natural and mainstream supermarkets nationwide. Additionally, the company’s products are sold through specialty gourmet food stores, retail stores, convenience … Continue reading →

RedHill Biopharma Ltd. (NASDAQ: RDHL) is an emerging Israeli biopharmaceutical company primarily focused on the development of late clinical-stage small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. The company’s current development pipeline is headlined … Continue reading →

RealNetworks, Inc. (NASDAQ: RNWK) creates innovative applications and services that make it easy for consumers to connect with and enjoy digital media on the devices and platforms they choose to use. The company invented the streaming media category in 1995, … Continue reading →

Rare Element Resources Ltd. (NYSE: REE) is a strategic materials company focused on delivering rare earth products for technology and defense applications by advancing its Bear Lodge project in northeast Wyoming. Bear Lodge is a significant mineralized district containing many … Continue reading →

RADCOM Ltd. (NASDAQ: RDCM) provides innovative service assurance and customer experience management solutions for leading telecom operators and communications service providers. The company specializes in solutions for next-generation mobile and fixed networks – including LTE, VoLTE, IMS, VoIP, UMTS/GSM and … Continue reading →